Barry T. Mori
Direttore Finanziario/CFO presso InterX, Inc.
Profilo
Barry T.
Mori is currently the Chief Financial Officer & Director at InterX, Inc. Previously, he worked as the Chief Financial Officer & Vice President at Perquest, Inc. Mori holds an MBA from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.
Posizioni attive di Barry T. Mori
| Società | Posizione | Inizio |
|---|---|---|
InterX, Inc.
 InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Direttore Finanziario/CFO | - |
Precedenti posizioni note di Barry T. Mori
| Società | Posizione | Fine |
|---|---|---|
Perquest, Inc.
 Perquest, Inc. Miscellaneous Commercial ServicesCommercial Services Perquest, Inc. provides online payroll and employer services. The company was founded by David E. Kahn in 2001 and is headquartered in Dublin, CA. | Direttore Finanziario/CFO | - |
Formazione di Barry T. Mori
| University of California, Los Angeles | Masters Business Admin |
| University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Perquest, Inc.
Perquest, Inc. Miscellaneous Commercial ServicesCommercial Services Perquest, Inc. provides online payroll and employer services. The company was founded by David E. Kahn in 2001 and is headquartered in Dublin, CA. | Commercial Services |
InterX, Inc.
InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Health Technology |
- Borsa valori
- Insiders
- Barry T. Mori
